• 한국약용작물학회지
• /
• 제25권5호
• /
• pp.269-281
• /
• 2017

Background: Small particles increase airway inflammation upon reaching the alveoli. Here, we investigated the protective or therapeutic effects of Salvia plebeia R. Br. (SP_R) extracts on airway inflammation. Methods and Results: To investigate the anti-inflammatory activity of SP_R extracts, we measured their inhibitory effect on the production of reactive oxygen species (ROS) expression of inflammatory mediators, and immune cell infiltration in MH-S alveolar macrophage cells and in the ambient particulate matter (APM)-exposed airway inflammation mice model. The SP_R extracts inhibited the production of ROS and expression of IL-4, IL-10, IL-15, and IL-17A mRNA in APM-stimulated MH-S cells. Oral administration of SP_R extracts suppressed APM-induced inflammatory symptoms, such as high alveolar wall thickness, excess collagen fibers, decreased mRNA expression of chemokines (Ccr9, Ccl5, Ccr3), inflammatory cytokines (IL-15, TNF-${\alpha}$), and IL-4 Th2 cytokine in the lung. The SP_R extracts also inhibited ROS production, granulocyte ($CD11b^+Gr-1^+$) infiltration, IL-17A, TNF-${\alpha}$, macrophage inflammatory protein (Mip-2), and chemokine (C-X-C motif) ligand 1 (Cxcl-1) production in the airway. The specific compounds in the SR-R extracts that mediate the anti-inflammatory effects were identified. Conclusions: In this study, SP_R extracts effectively inhibited airway inflammatory responses, such as ROS production and granulocyte infiltration into the airway, by regulating the expression of chemokines and inflammatory cytokines.

• The Korean Journal of Pain
• /
• 제34권2호
• /
• pp.176-184
• /
• 2021

Background: Diabetes-related neuropathic pain frequently occurs, and the underpinning mechanism remains elusive. The periaqueductal gray (PAG) exhibits descending inhibitory effects on central pain transmission. The current work aimed to examine whether inflammatory cytokines regulate mechanical allodynia and thermal hyperalgesia induced by diabetes through the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway in the PAG. Methods: Streptozotocin (STZ) was administered intraperitoneally to mimic allodynia and hyperalgesia evoked by diabetes in rats. Behavioral assays were carried out for determining mechanical pain and thermal hypersensitivity. Immunoblot and ELISA were performed to examine PAG protein amounts of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), as well as their corresponding receptors in STZ rats, and the expression of PI3K/protein kinase B (Akt)/mTOR signaling effectors. Results: Increased PAG p-PI3K/p-Akt/p-mTOR protein amounts were observed in STZ-induced animals, a PI3K-mTOR pathway inhibition in the PAG attenuated neuropathic pain responses. Moreover, the PAG concentrations of IL-1β, IL-6, and TNF-α and their receptors (namely, IL-1R, IL-6R, and tumor necrosis factor receptor [TNFR] subtype TNFR1, respectively) were increased in the STZ rats. Additionally, inhibiting IL-1R, IL-6R, and TNFR1 ameliorated mechanical allodynia and thermal hyperalgesia in STZ rats, alongside the downregulation of PI3K-mTOR signaling. Conclusions: Overall, the current study suggests that upregulated proinflammatory cytokines and their receptors in the PAG activate PI3K-mTOR signaling, thereby producing a de-inhibition effect on descending pathways in modulating pain transmission, and eventually contributing to neuropathic pain.

• The Korean Journal of Physiology and Pharmacology
• /
• 제16권1호
• /
• pp.11-16
• /
• 2012

Cancer stem cells (CSCs) are often characterized by the elevated expression of drug-resistance related stem-cell surface markers, such as CD133 and ABCG2. Recently, we reported that CSCs have a high level of expression of the IL-6 receptor (IL-6R). The purpose of this study was to investigate the effect of anticancer drugs on the expression of the drug resistance-related cancer stem cell markers, ABCG2, IL-6R, and CD133 in non-small cell lung cancer (NSCLC) cell lines. A549, H460, and H23 NSCLC cell lines were treated with the anticancer drugs 5-fluorouracil (5-FU; $25{\mu}g/ml$) and methotrexate (MTX; $50{\mu}g/ml$), and the expression of putative CSC markers was analyzed by fluorescent activated cell sorter (FACS) and the gene expression level of abcg2, il-6r and cd133 by reverse transcriptase-polymerase chain reaction (RT-PCR). We found that the fraction of ABCG2-positive(+) cells was significantly increased by treatment with both 5-FU and MTX in NSCLC cells, and the elevation of abcg2, il-6r and cd133 expressions in response to these drugs was also confirmed using RT-PCR. Also, the number of IL-6R(+) cells was increased by MTX in the 3 cell lines mentioned and increased by 5-FU in the H460 cell line. The number of CD133(+) cells was also significantly increased by both 5-FU and MTX treatment in all of the cell lines tested. These results indicate that 5-FU and MTX considerably enhance the expression of drug-resistance related CSC markers in NSCLC cell lines. Thus, we suggest that antimetabolite cancer drugs, such as 5-FU and MTX, can lead to the propagation of CSCs through altering the expression of CSC markers.

• 대한화장품학회지
• /
• 제32권1호
• /
• pp.59-64
• /
• 2006

문주란(Crinum asiaticum Linne var. japonicum)은 한국, 말레이지아 등 동남아시아 지역에서 관절통, 해열, 궤양 치료, 국부의 소염 및 해열 등의 목적에 민간요법 등으로 오래 전부터 사용되어 오고 있다. 본 연구에서는 이러한 문주란의 화장료 조성물로서의 가능성을 확인하기 위하여 iNOS (inducible nitric oxide synthase) 억제 그리고 PGE2, IL-6, and IL-8 방출 억제에 의한 항염 효능을 측정하였다. pH를 3.5로 조절하고 95% ethanol을 사용하여 추출한 후, HPLC 실험으로 문주란의 주성분이 면역조절물질로 잘 알려진 lycorine이며 대략 1% 정도 함유한 것을 확인하였고 그 함량은 문주란의 추출 부위 및 추출방법에 따라 달랐다. 리포다당(lipopolysaccharide, LPS)에 의해 활성화된 생쥐 대식세포(RAW 264.7 cells)에서 생성되는 NO 형성의 억제능을 측정한 항염실험에서, 문주란 에탄을 추출물은 투여량에 비례하는 저해능을 가지고 있음을 확인할 수 있었다($IC_{50} = 83.5 {\mu}g/mL$). 또한 RT-PCR법을 이용하여 문주란 에탄을 추출물이 iNOS 유전자 발현도 억제함을 확인하였다. 또한, 문주란 추출물은 전혀 세포독성을 보이지 않았으며 오히려 LPS에 대하여 세포증식효과를 나타내었다(세포생존율 약 $10{\sim}60%$ 증가). 인간의 섬유아세포에서 과산화수소에 의해 활성화된 PGE2, IL-6 및 IL-8 방출 억제효능 측정 실험에서는 0.05%와 1% 농도 이상에서 (PGE2와 IL-6의 분비가) 거의 완전히 억제됨을 확인할 수 있었고, 나아가서 IL-8의 경우는 모든 실험농도 범위에서 완전히 억제되었다(>0.0025%). 이러한 결과로부터 문주란의 추출물이 충분한 항염 효과를 가지고 있음을 확인할 수 있었다.

• Genomics & Informatics
• /
• 제9권3호
• /
• pp.114-120
• /
• 2011

Chronic inflammation has been implicated as one of the important etiological factors in insulin resistance and type 2 diabetes mellitus (T2DM). To investigate the role of anti-inflammatory cytokines in the development of T2DM, we conducted a case-control study to assess the association between IL4/IL4R polymorphisms and disease risk. We firstly identified single nucleotide poly-morphisms (SNP) at IL4 and IL4RA loci by sequencing the loci in Korean participants. Case-control studies were conducted by genotyping the SNPs in 474 T2DM cases and 470 non-diabetic controls recruited from community-based cohorts. Replication of the associated signals was performed in 1,216 cases and 1,352 controls. We assessed effect of IL4 -IL4RA interaction on T2DM using logistic regression method. The functional relevance of the SNP associated with disease risk was determined using a reporter expression assay. We identified a strong association between the IL4 promoter variant rs2243250 and T2DM risk (OR=0.77; 95% CI, 0.67~0.88; p=$1.65{\times}10^{－4}$ in the meta-analysis). The reporter gene expression assay demonstrated that the presence of rs2243250 might affect the gene expression level with ~1.5-fold allele difference. Our findings contribute to the identification of IL4 as a T2D susceptibility locus, further supporting the role of anti-inflammatory cytokines in T2DM disease development.

• 대한화장품학회지
• /
• 제32권4호
• /
• pp.249-255
• /
• 2006

본 연구는 백량금 추출물의 화장품 원료로서의 특성을 알아보기 위하여 항산화, 미백 및 항염 효과와 관련된 다양한 실험을 실시하였다. 70% 메탄을 추출물을 대상으로 실험한 결과 1,1-diphenyl-2-picryl-hydrazyl (DPPH) 라디칼 소거 효과는 0.01% 이상의 농도에서 90%의 효과를 나타내었고, 세포내 멜라닌 생성 억제 효과는 0.05% 이상의 농도에서 50% 이상의 효과를 나타내었다 이 후 70% 메탄을 추출물을 대상으로 MPLC를 사용하여 성분 분리 실험을 실시하여 5개의 분획들을 얻었고, 이들을 대상으로 실험한 결과 3번, 4번 그리고 5번 분획들에서 항산화(DPPH 라디칼 소거, Mn-SOD 생성 억제), 미백(멜라닌 생성 억제)그리고 항염($IL-1{\alpha}$, IL-6, COX-2, total NO 생성 억제)효과를 나타내었다.

• Molecules and Cells
• /
• 제19권2호
• /
• pp.180-184
• /
• 2005

IL-17 is a major proinflammatory cytokine secreted by activated T-lymphocytes that accumulates in the inflamed joints of rheumatoid arthritis (RA) patients. Additional IL-17-related molecules and their receptors have been discovered and may also contribute to RA pathogenesis. We examined the expression of the prototypic IL-17 (IL-17A) and its homologs, IL-17B-F, by RT-PCR analyses of synovial fluid mononuclear cells (SFMCs) and peripheral blood mononuclear cells (PBMCs) from RA patients. We also tested for induction of the IL-17 receptor homologs upon stimulation of the fibroblast-like synoviocytes (FLSs) of RA patients with IL-17. The patients' SFMCs expressed IL-17C, E and F in addition to IL-17A. As in the case of IL-17, IL-15 appears to be the major inducer of these homologs in RA SFMCs. We detected transcripts of IL-17R, as well as those of IL-17RB, C and D, in the FLSs of RA patients. Whereas IL-17R expression increased upon in vitro stimulation with IL-17, expression of IL-17RB, C and D was unchanged. However the possibility of cross-interaction between other IL-17 homologs and receptor isoforms remains to be investigated. Our data suggest that these additional homologs should also be considered as targets for immune modulation in the treatment of RA joint inflammation.

• 대한화장품학회지
• /
• 제48권4호
• /
• pp.303-312
• /
• 2022

본 연구에서는 향부자를 이용하여 에틸아세테이트로 분획물을 제조하고, 지표물질 α-cyperone의 함량을 확인하였다. 또한, 향부자 에틸아세테이트 분획물(EAFC) 및 α-cyperone의 항염증 및 가려움증 완화 효능평가를 통하여 기능성 소재로서의 가능성을 확인하였다. EAFC 내의 α-cyperone의 함량을 확인하기 위해 HPLC 분석을 실시한 결과, α-cyperone의 함량이 5.243%임을 확인하였다. EAFC 및 지표성분인 α-cyperone의 염증 완화 효과를 검증하기 위해 lipopolysaccharide (LPS)로 염증반응을 유도시킨 RAW 264.7 대식세포에서의 nitric oxide (NO) 생성 저해능을 확인한 결과, 농도의존적으로 NO 생성을 저해하였다. 추가적인 염증염증 유발 인자인 IL-1β, IL-6, TNF-α, COX-2 및 iNOS의 mRNA 발현 역시 농도의존적으로 저해하였다. EAFC를 함유한 간단한 화장품 제형을 이용하여 임상시험을 실시한 결과, sodium lauryl sulfate (SLS)로 유발된 피부 자극이 진정되는 효과 및 가려움증이 완화되는 효과를 확인하였다. 이를 통하여 향부자는 염증 저해 및 가려움증 완화 효과를 가지는 천연 화장품 원료로 사용 가능할 것으로 사료된다.

• Molecules and Cells
• /
• 제39권2호
• /
• pp.103-110
• /
• 2016

As a degenerative joint disease, osteoarthritis (OA) constitutes a major cause of disability that seriously affects the quality of life of a large population of people worldwide. However, effective treatment that can successfully reverse OA progression is lacking until now. The present study aimed to determine whether two small non-coding RNAs miR-29a and miR-140, which are significantly down-regulated in OA, can be applied together as potential therapeutic targets for OA treatment. MiRNA synergy score was used to screen the miRNA pairs that potentially synergistically regulate OA. An in vitro model of OA was established by treating murine chondrocytes with IL-$1{\beta}$. Transfection of miR-29a and miR-140 via plasmids was investigated on chondrocyte proliferation and expression of nine genes such as ADAMTS4, ADAMTS5, ACAN, COL2A1, COL10A1, MMP1, MMP3, MMP13 and TIMP metallopeptidase inhibitor 1 (TIMP1). Western blotting was used to determine the protein expression level of MMP13 and TIMP1, and ELISA was used to detect the content of type II collagen. Combined use of miR-29a and miR-140 successfully reversed the destructive effect of IL-$1{\beta}$ on chondrocyte proliferation, and notably affected the MMP13 and TIMP1 gene expression that regulates extracellular matrix. Although co-transfection of miR-29a and miR-140 did not show a synergistic effect on MMP13 protein expression and type II collagen release, but both of them can significantly suppress the protein abundance of MMP13 and restore the type II collagen release in IL-$1{\beta}$ treated chondrocytes. Compared with single miRNA transfection, cotransfection of both miRNAs exceedingly abrogated the suppressed the protein production of TIMP1 caused by IL-$1{\beta}$, thereby suggesting potent synergistic action. These results provided1novel insights into the important function of miRNAs' collaboration in OA pathological development. The reduced MMP13, and enhanced TIMP1 protein production and type II collagen release also implies that miR-29a and miR-140 combination treatment may be a possible treatment for OA.

• 대한수학회지
• /
• 제32권4호
• /
• pp.725-737
• /
• 1995

Let $X_t = (X_t^(1), X_t^(2))', t \geqslant 0$, be a real stationary 2-dimensional Gaussian process with $EX_t^(1) = EX_t^(2) = 0$ and $$ EX_0 X'_t = (_{\rho(t) r(t)}^{r(t) \rho(t)}), $$ where $r(t) \sim $\mid$t$\mid$^-\alpha, 0 < \alpha < 1/2, \rho(t) = o(r(t)) as t \to \infty, r(0) = 1, and \rho(0) = \rho (0 \leqslant \rho < 1)$. For $t > 0, u > 0, and \upsilon > 0, let L_t (u, \upsilon)$ be the time spent by $X_s, 0 \leqslant s \leqslant t$, above the level $(u, \upsilon)$.